STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:STE
CUSIP85915210
Phone44-13-3238-7100
Debt
Debt-to-Equity Ratio0.43
Current Ratio2.65
Quick Ratio2.02
Price-To-Earnings
Trailing P/E Ratio27.50
Forward P/E Ratio24.23
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.62 billion
Price / Sales3.68
Cash Flow$6.2526 per share
Price / Cash18.25
Book Value$37.92 per share
Price / Book3.01
Profitability
EPS (Most Recent Fiscal Year)$4.15
Net Income$290.91 million
Net Margins11.42%
Return on Equity11.80%
Return on Assets7.17%
Miscellaneous
Employees12,000
Outstanding Shares84,550,000
Market Cap$9.71 billion
Steris (NYSE:STE) Frequently Asked Questions
What is Steris' stock symbol?
Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."
How often does Steris pay dividends? What is the dividend yield for Steris?
Steris declared a quarterly dividend on Wednesday, August 8th. Shareholders of record on Wednesday, August 29th will be paid a dividend of $0.34 per share on Thursday, September 27th. This represents a $1.36 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date is Tuesday, August 28th. This is a boost from Steris's previous quarterly dividend of $0.31. View Steris' Dividend History.
How were Steris' earnings last quarter?
Steris PLC (NYSE:STE) released its earnings results on Wednesday, August, 8th. The medical equipment provider reported $1.00 EPS for the quarter, topping analysts' consensus estimates of $0.99 by $0.01. The medical equipment provider earned $638.76 million during the quarter, compared to analysts' expectations of $638.63 million. Steris had a return on equity of 11.80% and a net margin of 11.42%. The firm's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.85 EPS. View Steris' Earnings History.
When is Steris' next earnings date?
What guidance has Steris issued on next quarter's earnings?
Steris updated its FY19 earnings guidance on Wednesday, August, 8th. The company provided EPS guidance of $4.63-4.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.70.
What price target have analysts set for STE?
6 brokerages have issued 1-year price targets for Steris' shares. Their forecasts range from $16.00 to $125.00. On average, they expect Steris' stock price to reach $98.00 in the next year. This suggests that the stock has a possible downside of 14.1%. View Analyst Price Targets for Steris.
What is the consensus analysts' recommendation for Steris?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Steris.
What are Wall Street analysts saying about Steris stock?
Here are some recent quotes from research analysts about Steris stock:
- 1. KeyCorp analysts commented, "Our price target of $20/share is based on an equally-weighted composite of: (a) $21.3/share, as a 25x multiple of taxed and diluted $11.7 discounted back to FY18 at 30% (in line with the expected PE multiple and discount rate of an early development-stage biotechnology company); and (b) an NPV of $21.3/ share (discounted cash flow analysis using a 20% discount rate and 2.0% growth rate, in line with the expected discount and growth parameters of an early development-stage biotechnology company)." (8/9/2018)
- 2. According to Zacks Investment Research, "Over the past three months, STERIS has been outperforming its industry. We are also encouraged by STERIS witnessing favorable underlying market trends along with new product and service offerings. The company's strong organic growth across specialty services, life sciences and applied sterilization segments also buoys optimism. Further, growth in free cash flow reserve is indicative of the company’s strong cash balance. The company has also made certain divestments and organizational changes, which are expected to better align with its operations. On the flip side, a tough competitive landscape and currency headwinds continue to pose concerns. Moreover, STERIS' customers undergoing major consolidation pose threats for the company." (8/6/2018)
Who are some of Steris' key competitors?
Some companies that are related to Steris include Align Technology (ALGN), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Halyard Health (HYH), CONSORT Med PLC/S (CSRMY), Sientra (SIEN), Invacare (IVC) and Establishment Labs (ESTA).
Who are Steris' key executives?
Steris' management team includes the folowing people:
- Mr. Walter M. Rosebrough Jr., CEO, Pres & Director (Age 64)
- Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
- Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
- Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies & Life Sciences (Age 45)
- Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)
Has Steris been receiving favorable news coverage?
News headlines about STE stock have trended positive on Saturday, according to Accern. Accern ranks the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Steris earned a daily sentiment score of 0.26 on Accern's scale. They also gave media coverage about the medical equipment provider an impact score of 45.21 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term. View Recent Headlines for Steris.
Who are Steris' major shareholders?
Steris' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.99%), Janus Henderson Group PLC (8.94%), FMR LLC (3.07%), Massachusetts Financial Services Co. MA (2.56%), Fisher Asset Management LLC (1.70%) and Bessemer Group Inc. (1.60%). Company insiders that own Steris stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.
Which major investors are selling Steris stock?
STE stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Janus Henderson Group PLC, Dividend Assets Capital LLC, Canada Pension Plan Investment Board, Public Employees Retirement Association of Colorado, American Century Companies Inc., Russell Investments Group Ltd. and Chicago Equity Partners LLC. Company insiders that have sold Steris company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for Steris.
Which major investors are buying Steris stock?
STE stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Fiera Capital Corp, BlackRock Inc., Envestnet Asset Management Inc., Wells Fargo & Company MN, Millennium Management LLC, Frontier Capital Management Co. LLC and First Trust Advisors LP. View Insider Buying and Selling for Steris.
How do I buy shares of Steris?
Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Steris' stock price today?
One share of STE stock can currently be purchased for approximately $114.11.
How big of a company is Steris?
Steris has a market capitalization of $9.71 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. Steris employs 12,000 workers across the globe.
How can I contact Steris?
Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]
MarketBeat Community Rating for Steris (NYSE STE)
MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.
